Grant: Master's Award: Canada Graduate Scholarships
Memorial University of Newfoundland
$17,500.00
Alcohol use disorder in Newfoundland and Labrador: exploring primary care providers screening practices, diagnosis and pharmacologic management
EF 2022-23
Résumé
The ability to screen for, diagnose and, in many cases, manage alcohol use disorder (AUD) in the outpatient setting is within the scope of Canadian primary care providers (PCPs). Alcohol-related harms have substantial impacts on both the individual and greater society. While evidence-based recommendations for identification and management of AUD exist, data is sparse provincially and nationally on how these recommendations are employed and what barriers exist to them being implemented. Additionally, recent studies have shown that AUD pharmacotherapy is critically under-utilized.
Newfoundland and Labrador (NL) reports the highest per capita alcohol consumption and the highest per capita rates of heavy drinking. Despite these grim statistics, there are no studies exploring how PCPs in NL approach AUD or what barriers exist to the management of AUD. This is a critical time for this research as NL released in July 2022 the Provincial Alcohol Action Plan, and both first-line pharmacotherapy options for AUD are now open benefit under the provincial drug formulary. This means more patients are eligible to access these medications.
This proposed study consists of the development and distribution of a survey to PCPs across NL to understand how AUD is identified and managed - including comfort level and barriers to prescribing pharmacotherapy. Then, through collaboration with the NL Centre for Health Information, eDOCSNL, and the NL Prescription Drug Program, I will gather and analyze data on the prescription of AUD pharmacotherapy and the diagnosis of AUD at sites participating in the provincial EMR. Results will help identify areas to support PCPs with AUD identification and management, as well as to provide a picture of AUD and sociodemographic characteristics across NL.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Newfoundland and Labrador, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486440
Name
Hasan Hiliary C
Region
Newfoundland and Labrador
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Alcohol use disorder in Newfoundland and Labrador: exploring primary care providers screening practices, diagnosis and pharmacologic management
Programtype2
Studentship Programs
Orgnameinp2
Memorial University of Newfoundland
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acamprosate; Alcohol Use Disorder; Family Medicine; Naltrexone; Newfoundland And Labrador; Nurse Practitioner; Rural; Urban
Abstract
The ability to screen for, diagnose and, in many cases, manage alcohol use disorder (AUD) in the outpatient setting is within the scope of Canadian primary care providers (PCPs). Alcohol-related harms have substantial impacts on both the individual and greater society. While evidence-based recommendations for identification and management of AUD exist, data is sparse provincially and nationally on how these recommendations are employed and what barriers exist to them being implemented. Additionally, recent studies have shown that AUD pharmacotherapy is critically under-utilized.
Newfoundland and Labrador (NL) reports the highest per capita alcohol consumption and the highest per capita rates of heavy drinking. Despite these grim statistics, there are no studies exploring how PCPs in NL approach AUD or what barriers exist to the management of AUD. This is a critical time for this research as NL released in July 2022 the Provincial Alcohol Action Plan, and both first-line pharmacotherapy options for AUD are now open benefit under the provincial drug formulary. This means more patients are eligible to access these medications.
This proposed study consists of the development and distribution of a survey to PCPs across NL to understand how AUD is identified and managed - including comfort level and barriers to prescribing pharmacotherapy. Then, through collaboration with the NL Centre for Health Information, eDOCSNL, and the NL Prescription Drug Program, I will gather and analyze data on the prescription of AUD pharmacotherapy and the diagnosis of AUD at sites participating in the provincial EMR. Results will help identify areas to support PCPs with AUD identification and management, as well as to provide a picture of AUD and sociodemographic characteristics across NL.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hasan, Hiliary C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~